-
October 04, 2012
Theravance Inc. (THRX) recently announced that it has entered into an agreement with a privately held, Italy based ...
-
September 19, 2012
GlaxoSmithKline plc (GSK) recently announced that it is seeking to expand the label of Synflorix in EU and has ...
-
September 18, 2012
GlaxoSmithKline (GSK) recently announced it has hiked its stake in Response Genetics Inc. (RGDX), a company focused ...
-
September 05, 2012
The market is on the rise this morning. The Nasdaq has increased 0.2%; the S&P 500 has risen 0.2%; and the Dow is ...
-
September 04, 2012
The market is currently down, with the Nasdaq slipping 0.8%, the S&P 500 down 0.6% and the Dow declining 0.8%. The ...
-
August 31, 2012
The market is on the rise this morning. The Nasdaq has climbed 0.8%; the S&P 500 is up 0.8%; and the Dow has risen ...
-
August 29, 2012
Currently, the Nasdaq has decreased 0.2%, the S&P 500 has been relatively flat and the Dow has remained steady. The ...
-
August 28, 2012
On a bad day for the market, the Nasdaq has slipped 0.1%, the S&P 500 is trading down 0.1% and the Dow has decreased ...
-
August 27, 2012
GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) recently announced that they have completed the phase III program ...
-
August 27, 2012
The market is on the rise this morning. The Nasdaq is up 0.5%; the S&P 500 has risen 0.3%; and the Dow has climbed ...
-
August 01, 2012
Theravance Inc. (THRX) reported second-quarter 2012 loss of 42 cents per share, slightly narrower than the Zacks ...
-
July 19, 2012
Glaxo Group Limited, an affiliate of GlaxoSmithKline (GSK), and Amicus Therapeutics (FOLD) recently announced the ...
-
July 17, 2012
The Nasdaq has slipped 0.1%, the S&P 500 has declined 0.1% and the Dow is trading down 0.2% on a bad morning for the ...
-
July 16, 2012
GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) recently announced the submission of regulatory applications for ...
-
July 11, 2012
Theravance Inc. (THRX) recently announced positive top-line results on TD-1211 from a phase IIb study, 0084. TD-1211 ...
-
July 03, 2012
GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) recently announced data from four pivotal phase III studies ...
-
July 03, 2012
The market is doing well so far today. The Nasdaq has moved up 0.7%; the S&P 500 is up 0.7%; and the Dow has risen ...
-
July 02, 2012
The market is currently down, with the Nasdaq falling 0.2%, the S&P 500 down 0.2% and the Dow decreasing 0.5%. The ...
-
June 19, 2012
We have maintained our Neutral recommendation on Theravance, Inc. (THRX) with a target price of $20.00 per share. ...
-
June 13, 2012
GlaxoSmithKline (GSK) recently announced that its subsidiary, Stiefel, has entered into an agreement with Basilea ...
